Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dicycle vs Tri-cycle High-dose Dexamethasone in Adult ITP
NCT06913374Phase 3Not yet recruiting
- Sponsor
- Shandong University
- Start
- May 2025
- Primary completion
- May 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexamethasone in primary immune thrombocytopenia (ITP) (2 arms), sponsored by Shandong University. Primary endpoint: Sustained response at Month 6. Planned start May 2025; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
primary immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT06913374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06913374.